Evaluation of the efficacy of topical corticosteroids.
D000287:Administration, Topical; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage* / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents; D001623:Betamethasone / Q000627:therapeutic use; D005446:Fluocinolone Acetonide / Q000627:therapeutic use; D006801:Humans; D007664:Ketosteroids / Q000627:therapeutic use; D008297:Male; D011282:Pregnenediones / Q000627:therapeutic use; D012867:Skin / Q000187:drug effects; D013259:Steroids, Fluorinated / Q000627:therapeutic use; D014222:Triamcinolone Acetonide / Q000627:therapeutic use; D014662:Vasoconstrictor Agents
D000305:Adrenal Cortex Hormones; D000893:Anti-Inflammatory Agents; D007664:Ketosteroids; D011282:Pregnenediones; D013259:Steroids, Fluorinated; D014662:Vasoconstrictor Agents; D005446:Fluocinolone Acetonide; D001623:Betamethasone; D014222:Triamcinolone Acetonide